Business Context and Reporting Period
Company: Carlsmed, Inc. (CARL)
Filing Type: Form 8-K (Current Report)
Report Date: February 25, 2026
Reporting Period: Fourth quarter and fiscal year ended December 31, 2025.
Context: The filing announces the issuance of a press release detailing financial results for the specified period. The full text of the press release is provided as Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text serves as a notification of the results and incorporates the press release by reference. It does not contain specific numerical data within the body of the filing.
- Revenue: Not provided in the filing text.
- Profit/Loss: Not provided in the filing text.
- Cash Flow: Not provided in the filing text.
- Margins: Not provided in the filing text.
- Debt and Liquidity: Not provided in the filing text.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for this information.
Guidance, Outlook, and Risks
The filing text does not contain specific guidance, outlook, management commentary, risks, contingencies, or unusual items. These details are contained within the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2025 financial figures.
- Verify year-over-year revenue and net income trends in the attached press release.
- Check the press release for updated cash runway and liquidity positions.
- Confirm any new clinical trial milestones or regulatory updates mentioned in the press release.
- Review the press release for any revised forward-looking guidance or strategic shifts.